The changing epidemiology of cystic fibrosis
- PMID: 8419592
- DOI: 10.1016/s0022-3476(05)83478-x
The changing epidemiology of cystic fibrosis
Abstract
Data from 17,857 patients with cystic fibrosis submitted in 1990 to the registry maintained by the Cystic Fibrosis Foundation were used to described their demographic characteristics, survival rates, pulmonary function, anthropometry, microbiologic data, complication rates, and health care utilization. Comparisons with similar data collected in 1969, 1972, and 1978 demonstrated a significant shift in the age distribution of patients with cystic fibrosis. The proportion of adult patients increased fourfold between 1969 (8%) and 1990 (33%). In 1990 the median age of all patients in the cystic fibrosis registry was 12.5 years; the median age at diagnosis was 7 months; cystic fibrosis was diagnosed in 90% of all patients by age 12 years. Meconium ileus at birth was reported for 16% of all patients with a new diagnosis in 1990. Median survival age doubled between 1969 and 1990, from 14 to 28 years. Female patients consistently had a lower median survival age than male patients (25 vs 30 years in 1990). The most frequently reported respiratory pathogen was Pseudomonas aeruginosa, cultured in specimens from 61% of all patients, ranging from 21% of those less than 1 year of age to more than 80% of those aged 26 years or older. Overall, patients with cystic fibrosis are living much longer than in the past but still have chronic pulmonary infections and other medical complications related to their disease, including diabetes, intestinal obstruction, cirrhosis, hemoptysis, and pneumothorax.
Comment in
-
Digestive-tract cancer in cystic fibrosis.J Pediatr. 1993 Jul;123(1):172. doi: 10.1016/s0022-3476(05)81578-1. J Pediatr. 1993. PMID: 8320618 No abstract available.
Similar articles
-
[Italian Cystic Fibrosis Registry. Report 2011-2014].Epidemiol Prev. 2018 Jan-Feb;42(1S1):1-32. doi: 10.19191/EP18.1-S1.P001.001. Epidemiol Prev. 2018. PMID: 29506377 Italian.
-
The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.Dev Period Med. 2015 Jan-Mar;19(1):66-79. Dev Period Med. 2015. PMID: 26003072
-
[Italian Cystic Fibrosis Register - Report 2010].Epidemiol Prev. 2016 Mar-Apr;40(2 Suppl 2):1-47. doi: 10.19191/EP16.2S2.P001.074. Epidemiol Prev. 2016. PMID: 27291389 Italian.
-
Diagnosis and treatment of cystic fibrosis. An update.Chest. 1984 Jun;85(6):802-9. doi: 10.1016/s0012-3692(16)62421-2. Chest. 1984. PMID: 6373170 Review.
-
Background and Epidemiology.Pediatr Clin North Am. 2016 Aug;63(4):567-84. doi: 10.1016/j.pcl.2016.04.001. Pediatr Clin North Am. 2016. PMID: 27469176 Free PMC article. Review.
Cited by
-
Morphological chest CT changes in cystic fibrosis and massive hemoptysis.Radiologie (Heidelb). 2024 Nov;64(Suppl 1):76-85. doi: 10.1007/s00117-024-01266-4. Epub 2024 Feb 7. Radiologie (Heidelb). 2024. PMID: 38326635 Free PMC article.
-
One Center's Guide to Outpatient Management of Pediatric Cystic Fibrosis Acute Pulmonary Exacerbation.Clin Med Insights Pediatr. 2016 Jul 12;10:57-65. doi: 10.4137/CMPed.S38336. eCollection 2016. Clin Med Insights Pediatr. 2016. PMID: 27429564 Free PMC article.
-
Microarray analysis reveals induction of lipoprotein genes in mucoid Pseudomonas aeruginosa: implications for inflammation in cystic fibrosis.Infect Immun. 2004 Sep;72(9):5012-8. doi: 10.1128/IAI.72.9.5012-5018.2004. Infect Immun. 2004. PMID: 15321993 Free PMC article.
-
Cystic fibrosis in Tunisian children: a review of 32 children.Afr Health Sci. 2018 Sep;18(3):664-670. doi: 10.4314/ahs.v18i3.24. Afr Health Sci. 2018. PMID: 30602999 Free PMC article.
-
Early antibiotic treatment of pseudomonas aeruginosa colonisation in cystic fibrosis: a critical review of the literature.Eur J Clin Pharmacol. 2004 Apr;60(2):67-74. doi: 10.1007/s00228-004-0735-2. Epub 2004 Mar 5. Eur J Clin Pharmacol. 2004. PMID: 15004732 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous